Behavior
Conduct extensive pain, sensory, motor, and cognitive behavioral testing.
MD Biosciences offers acute inflammatory pain models that can be extended to evaluate a more chronic inflammatory pain state. In models like CFA or carrageenan, we can measure the release of cytokines and their role in the initiation and maintenance of the inflammatory response.
Available in both mouse and rat models, the CFA-induced inflammatory pain model exhibits peripheral tissue injury following an injection of complete freund's adjuvant (CFA).
Available in both mouse and rat models, the carrageenan-induced inflammatory pain model induces a short-lasting acute inflammation and hyperalgesia.
Biomarker analysis provides precise insights into pro- and anti-inflammatory cytokines in paw skin, CSF, and plasma, uncovering both local and systemic drug effects. The graphs illustrate a significant reduction in pro- and anti-inflammatory cytokines within the CFA rat model, indicating a reduction in the pro-inflammatory response.
MD Biosciences offers comprehensive in vivo measures and endpoint assessments, delivering robust data packages to support critical research decisions in the evolving landscape of drug development and biomedical research.
Conduct extensive pain, sensory, motor, and cognitive behavioral testing.
Explore inflammatory and pain biomarkers in disease-specific tissues.
Characterize tissue and cellular changes in disease, pain, and neurodegeneration.